Market Overview:
The global influenza medications market size is expected to reach USD 1,386.21 million by 2032, exhibiting the CAGR of 4.3% during the forecast period.
Market Introduction
Influenza, commonly referred to as flu, is a viral infection that affects the throat, nose, and lungs. The symptoms of flu usually come on suddenly and take the form of cough, sore throat, fever, runny nose, headaches, and fatigue. Flu typically causes mild illness, but negligence can lead to severe illness or even death. The symptoms of influenza can be managed by taking ample rest and consuming plenty of fluids. But in case of a more severe infection, healthcare professionals may prescribe an antiviral medicine for treating the flu. These medications can take the form of oseltamivir, baloxavir, and zanamivir. Baloxavir and oseltamivir are intended for oral consumption, whereas zanamivir is inhaled using a device similar to an asthma inhaler.
Download Free Sample PDF Copy of the Report:
Industry Participants
The market for influenza medications is fragmented. The major industry participants are competing on numerous factors to gain a larger share of the industry. Some of the top players operating in the market are:
- AbbVie (US)
- AstraZeneca (UK)
- Bayer AG (Germany)
- Bharat Biotech (India)
- BioCryst Pharmaceuticals (US)
- Daiichi Sankyo (Japan)
- Mylan (US)
- Novartis AG (Switzerland)
- Roche Diagnostics (Switzerland)
- Sanofi SA (France)
- Seqirus (Australia)
Segmental Analysis
- The influenza medications market segmentation is primarily based on influenza type, treatment, distribution channel, and region.
- By influenza type insights, the influenza A segment accounted for the largest market share owing to the rising number of cases of this influenza type.
- By treatment insights, the oseltamivir segment held the maximum revenue share due to its widespread adoption as a prescribed drug.
Influenza Medications Market, Influenza Type Outlook (Revenue – USD Million, 2019-2032)
- Influenza A
- Influenza B
Influenza Medications Market, Treatment Outlook (Revenue – USD Million, 2019-2032)
- Baloxavir Marboxil
- Oseltamivir Phosphate
- Others
Influenza Medications Market, Distribution Channel Outlook (Revenue – USD Million, 2019-2032)
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others